Compliance Radar
Who was sanctioned, and for what?
Fines, court rulings and incidents from Europe and North America: 756 cases from 32 jurisdictions, each with an official source and checked against that source before publication. Filter by country, area of law and sector. Click a chart to drill down one level.
Click a bar to drill down one level.
Where?
by regionAll jurisdictions
What for?
by action- Fine €1.8m 100 % · 1 case
- Order — 0 % · 1 case
Who?
by companyWhen?
per quarter, by date of decision| Period | Cases | Total |
|---|---|---|
| Q3 2023 | 0 | — |
| Q4 2023 | 0 | — |
| Q1 2024 | 0 | — |
| Q2 2024 | 0 | — |
| Q3 2024 | 0 | — |
| Q4 2024 | 1 | €1.8m |
| Q1 2025 | 0 | — |
| Q2 2025 | 0 | — |
| Q3 2025 | 0 | — |
| Q4 2025 | 0 | — |
| Q1 2026 | 0 | — |
| Q2 2026 | 0 | — |
| Q3 2026 | 1 | — |
2 cases
14 Aug 2026 Henkel AG & Co. KGaAHenkel/Liquid Nails: court blocks takeover of Loctite’s main competitor Order
Henkel wanted to buy the construction adhesive brand Liquid Nails for 725 million USD from the financial investor American Industrial Partners, thereby taking over the main competitor of its Loctite brand. After a seven-day trial, the federal court, on application by the Federal Trade Commission (FTC), issued a permanent injunction against the acquisition.
Acquiring the closest competitor carries a high risk of prohibition, even at a moderate deal volume.
- Authority / court
- U.S. District Court for the Southern District of New York (auf Antrag der FTC)
- Area of law
- Competition law · Merger control
- Legal basis
- Section 7 Clayton Act; Section 13(b) FTC Act (Permanent Injunction)
- Action
- Order
- Status of proceedings
- unknown
- Sector
- Chemicals and pharmaceuticals
- Employees
- 10,000 or more
- Published
- 17 Aug 2026
- Statement on FTC Win Blocking Loctite, Liquid Nails Construction Adhesive Merger (17.08.2026) Press release of an authority
Checked against the official source on 25 Sep 2026 · Direct link
Report an error
22 Nov 2024 Viatris Inc.Viatris: 1.5 million GBP – key staff replaced despite hold-separate order €1.8m
During the review of the sale of the European rights to the hormone products Duphaston and Femoston to Theramex, an Initial Enforcement Order was in force. Viatris replaced members of the UK management without the consent of the Competition and Markets Authority (CMA) and subsequently failed to report the breach; the CMA imposed 1.5 million GBP.
During a merger review, staffing decisions in the target business also require consent – and breaches must be reported immediately.
Standstill and interim obligations in merger proceedings (management, HR)
- Authority / court
- Competition and Markets Authority (CMA)
- Area of law
- Competition law · Merger control
- Legal basis
- Enterprise Act 2002, s. 72(2) (Initial Enforcement Order), s. 94A
- Action
- Fine
- Status of proceedings
- unknown
- Sector
- Chemicals and pharmaceuticals
- Employees
- 10,000 or more
Original amount 1,500,000 GBP, converted at the ECB reference rate of 22 Nov 2024.
- CMA: Viatris fined £1.5m for failure to comply with CMA order (22.11.2024) Press release of an authority
Checked against the official source on 25 Sep 2026 · Direct link